Background: Moderate alcohol consumption is cardioprotective. The mechanism for this beneficial effect might be reduced inflammatory responses, as suggested by prospective studies and small clinical trials in men. No studies have evaluated the antiinflammatory effects of wine in women. Objective: We investigated whether low-dose intake of white and red wines has differential effects on inflammatory markers in women. Design: In a crossover study, we randomly assigned 35 healthy women to two 4-wk periods of 20 g ethanol/d as white or red wine, preceded by two 4-wk washout periods. Before and after interventions, we measured serum lipids, circulating inflammatory biomarkers, cellular adhesion molecules (CAMs), and adhesion of monocytes to stimulated endothelial cells. Results: HDL cholesterol increased, and the serum concentrations of high-sensitivity C-reactive protein, intercellular adhesion molecule-1, CD40L, and interleukin-6 decreased after either wine (P 0.01, all). Vascular CAM-1 and E-selectin decreased (P 0.01) only after red wine. CAM expression by mononuclear cells was blunted after either wine, with a greater suppressant effect of red wine. Enhanced adhesion of monocytes to stimulated endothelial cells was reduced by 51% (95% CI: Ҁ57%, Ҁ45%) after white wine and by 89% (95% CI: Ҁ96%, Ҁ82%) after red wine (P ҃ 0.01 for between-wine differences). Conclusions: Moderate wine consumption is associated with beneficial effects on various inflammatory pathways related to endothelial activation in women. Probably because of its higher polyphenol content, red wine shows superior antiinflammatory effects than does white wine. Reducing low-grade inflammation and endothelial activation may be another potential mechanism by which alcoholic beverages exert their cardioprotective effect.
INTRODUCTION
The protective effect of moderate alcohol consumption against ischemic heart disease (IHD) has been established in many epidemiologic studies (1) (2) (3) (4) (5) . Because only one-half of this protective effect may be attributed to the increase in serum HDL cholesterol observed in moderate alcohol drinkers (3), mechanisms other than lipid effects may be involved in the association between moderate alcohol consumption and reduced IHD rates (2, 6, 7) . The atherosclerotic process underlying IHD is currently considered an inflammatory disease (8) . Findings from large cohort studies suggest that moderate alcohol consumption is associated with a reduction in serum inflammatory biomarkers (7, 9 -12) . In addition, clinical trials in men have shown a reduction of both circulating markers of inflammation and monocyte adhesion to endothelial cells after daily intake of 30 g alcohol as red wine (13, 14) . It is unknown, however, whether in women doses of alcohol lower than those considered safe in men taken as wine are sufficient to elicit antiinflammatory effects similar to those observed in men. Therefore, we performed a randomized crossover study in women to evaluate the effects of moderate consumption (20 g alcohol/d) of 2 alcoholic beverages with high (red wine) or low (white wine) polyphenol content, respectively, on inflammatory markers associated with endothelial dysfunction and on monocyte adhesion to endothelial cells.
SUBJECTS AND METHODS

Subjects
Thirty-six healthy female employees of our institution who reported an average daily ethanol intake ranging from 10 to 20 g during the past 5 y were recruited into a protocol approved by the institutional review board and gave informed consent. Eligibility criteria were age of 20 -50 y; absence of family history of premature IHD; no tobacco smoking, hypertension, or diabetes mellitus; LDL cholesterol 160 mg/dL; and HDL cholesterol 35 mg/dL. None of the women was taking oral contraceptives, medication of any sort, or vitamin supplements. The reported prior intake of alcohol was 7.8 Ȁ 6.3 g/d during a period of 16 Ȁ 12 y. Participants received free wine but no monetary compensation. The baseline characteristics of the participants are shown in Table 1 .
Study design
The study was an open, randomized crossover trial. To equilibrate hormonal influences on adhesion molecules, all biological measurements were performed on the first day of the menstrual cycle. The study design included a 4-wk run-in period (coinciding with the menstrual cycle) during which all subjects abstained from alcohol and consumed a prescribed Mediterranean-type diet with average energy intake as 20% protein, 47% carbohydrate, and 33% fat (8% saturated fatty acids, 20% monounsaturated fatty acids, and 5% polyunsaturated fatty acids). After this period, participants were individually randomly assigned in a crossover design between 2 isocaloric diet sequences for 4-wk periods, containing either red wine or white wine. Between the first and second wine sequence, there was a 4-wk washout period with alcohol abstention. All subjects received daily doses of 20 g ethanol as red wine or white wine (1 glass of 100 mL at lunch and at dinner). Dietary habits and physical activity were monitored before and at the end of each intervention treatment, when body weight and blood pressure were measured and blood and urine samples were collected.
Wine polyphenol content
Red and white wines were obtained from Tempranillo and Xarello grapes, with an alcoholic strength of 13.5% and 13%, respectively. The selection of wines was based on the wine's polyphenol content, which was determined by HPLC as described (15) . The total polyphenol, resveratrol, and anthocyanin contents of red wine were 1945 mg/L, 12.8 mg/L and 164.85 mg/L, respectively. White wine provided 308 mg/L polyphenols and 1.3 mg/L resveratrol, and anthocyanin was below detection limits.
Diet and exercise monitoring
The background diets were designed according to the subject's personal preferences. Consumption of dispensable foods rich in polyphenols or other potent antioxidants, such as onions, virgin olive oil, and green and black tea, was discouraged. Other foods with a high content in polyphenols, ascorbic acid, ␣-tocopherol, or ␤-carotene, such as cocoa, chocolate, orange and tomato juices, nuts, some fruit (oranges, lemons, strawberries, grapes, melon, apples, and apricots), some vegetables (spinach, turnips, carrots, parsley, peppers, garlic, and tomatoes), and soybean products were restricted. Natural foods rich in antioxidants, especially fruit and vegetables, were controlled so that individual diets had similar antioxidant content throughout the study.
Diet compliance was assessed from 3-d diet records administered by the same trained physician before and after each intervention (2 washout periods and 2 intervention treatments). These questionnaires were previously validated in our population (16) . Foods were converted to nutrients by using the PROFES-SIONAL DIET BALANCER software (Cardinal Health Systems Inc, Edina, MN). Physical activity was monitored with the Minnesota Leisure Time Physical Activity Questionnaire, which has also been validated in Spain (17) . At the end of the study, a clinician assessed any adverse effects from the interventions by administering a checklist of symptoms, including bloating, fullness, or indigestion; altered bowel habit; dizziness; and other symptoms possibly associated with wine intake.
Laboratory measurements
Fasting blood samples and a spot urine specimen were obtained at the end of each 4-wk period (run-in, first wine, washout, and second wine). Blood lipid measurements and immunophenotyping of peripheral blood mononuclear cells (PBMCs) were performed immediately. Serum and EDTA-plasma samples were stored at Ҁ80°C for analysis of inflammatory and cell adhesion molecules at the end of the study. Cholesterol and triacylglycerols were measured with the use of enzymatic procedures. HDL cholesterol was quantified after precipitation with phosphotungstic acid and magnesium chloride. Analyses determined by subject in frozen samples of whole serum or plasma as appropriate were homocysteine by fluorescence polarization immunoassay; high-sensitivity C-reactive protein (hsCRP) by particle-enhanced immunonephelometry; and interleukin-6, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, P-selectin, and CD40L by standard enzyme-linked immunoabsorbent assay (Bender MedSystems, Vienna, Austria). Intraassay and interassay CVs for hsCRP, interleukin-6, ICAM-1, VCAM-1, E-selectin, P-selectin, and CD40L ranged from 1.8% to 5.4% and 0.9% to 9.9%, respectively.
All analyses were done in duplicate. As a measure of intervention compliance, urinary resveratrol metabolites and anthocyanins were measured by HPLC before and after each intervention, as previously reported (18, 19) . 
PBMC immunophenotyping
PBMCs were obtained from whole blood by the FicollHypaque (Pharmacia, Uppsala, Sweden) method (20) . To measure PBMC expression of cell adhesion molecules (CAMs), a double direct immunofluorescence test was performed with commercial fluorochrome-conjugated monoclonal antibodies. Data analyses were performed with a FACScan Clinical Cytometer (Becton Dickinson, San Jose, CA) with the use of CELLQUEST software (version 7.5.3; Becton Dickinson, Aoust, Belgium). The following CAMs were measured: very late activation antigen-4 (VLA-4; anti-CD49d; Clone 44H6; Cytogmos, Barcelona, Spain), lymphocyte function-associated antigen-1 (anti-CD11a; (Clone R7.1; Bender MedSystems), ␣M␤2 (Mac-1; anti-CD11b; Clone LM2/1; Bender MedSystems), and Syalil-Lewis X (anti-CD15s, Clone CSLEx1; BD Biosciences, San Jose, CA).
We also measured the expression of monocyte chemoattractant protein-1 (Pharmingen, San Diego, CA,) and CD40 on the cell surface. Monocytes and T lymphocytes were identified with the use of anti-CD14 and anti-CD2 monoclonal antibodies (Caltag Laboratories, Burlingame, CA), respectively.
Monocyte-endothelium adhesion assay
After obtaining a suspension of PBMCs with the FicollHypaque method, cells were labeled with microbeads (monoclonal antibodies bound to magnetic particles) and were submitted to a magnetic field, which resulted in the isolation of an enriched monocyte population (95% CD14 ѿ cells, as assessed by flow cytometry). Cell viability was determined by the Trypan blue dye exclusion test (Sigma-Aldrich, Irvine, CA). The endothelial cell line used was Ea.hy926, which is a fusion product between the human umbilical vein endothelial cell line and the epithelial cell line A549, and was processed as previously reported (14) . Endothelial Ea.hy926 cell monolayers were grown to confluence in 96-well tissue culture plates (Nunc, Roskilde, Denmark). The endothelium adhesion assay was performed under nonstimulated and stimulated conditions [human recombinant tumor necrosis factor-␣ (TNF-␣) 10 ng/mL]. We added 1.5 ҂ 10 5 human monocytes/well (30 min at 37°C) to allow the adhesion. After that, nonadherent cells were removed by aspiration, and the wells were washed. Adherent cells were fixed and stained with 0.2% crystal violet in 20% methanol in phosphate-buffered saline for 20 min and were washed repeatedly with distilled water. After solubilization with 1% sodium dodecyl sulfate, adhesion was measured in units of absorbance with a spectrophotometer at a wavelength of 600 nm (Multiskan RC ThermoLabsystems, Helsinki, Finland). The adhesion assay, for each subject and condition, was performed in quadruplicate.
Statistical analyses
For a crossover design, statistical power calculations indicated that to detect mean differences of 10 mean fluorescence intensity in VLA-4 in monocytes with a conservative SD of 10 mean fluorescence intensity (13), 32 subjects per group would need to complete the study (␣ risk ҃ 0.05; power ҃ 0.8). Although the VLA-4 adhesion molecule measurement was used to set sample size, changes in all endpoints were of equal interest in this study. Descriptive statistics with means and SDs were used for the baseline characteristics of the participants. Values with a skewed distribution (hsCRP, VCAM-1, ICAM-1, and interleukin-6) were transformed to their ln for analyses. Changes in clinical outcomes were assessed with repeated-measures analysis of variance with 3 factors: wine (red wine compared with white wine), time (before compared with after intervention), and wine sequence. Treatment (wine) and time were factors with repeated measures. No carryover effect between wine treatments (period sequence) was found for any variable. Therefore, final analyses were performed with repeated-measures analysis of variance for the 2 factors wine and time and their interactions. Within-and between-group differences are expressed as means and 95% CIs. All statistical tests were 2-tailed, and the significance level was 0.05. Analyses were performed with the use of SPSS, version 11.0 (SPSS Inc, Chicago, IL).
RESULTS
Patient characteristics and diets
Of the 36 participants randomly assigned to intervention, 35 completed all study periods. One woman withdrew before completing the 2 phases of the study. Her baseline characteristics were similar to those of the overall group. The women who finished the trial had a mean age of 38 y (range: 23-50 y). Seventeen participants consumed first red wine for 4 wk and after the washout period switched to white wine for the ensuing 4 wk, whereas 18 subjects followed the same interventions in reverse order.
According to participants' reports and recounts of empty bottles, compliance with intake of both red and white wines was 100%. As an objective measure of intervention compliance, resveratrol metabolites were measured in urine. As expected, urine concentration of total resveratrol metabolites (cis-and transresveratrol glucoronides) increased from 51. these metabolites after the red wine period in comparison to its correspondent washout period. The differences between the changes observed in urinary resveratrol concentrations after intakes of white and red wines significantly favored red wine (P ҃ 0.005). In addition, urinary anthocyanin concentrations were measured, as a measure of red wine intake, which increased a mean of 0.077 ng malvidin glycoside/mg creatinine (95% CI: 0.015, 0.140 ng malvidin glycoside/mg creatinine) during red wine intake (P ҃ 0.02), whereas it remained practically unchanged after white wine intake, with a mean change of 0.0002 ng malvidin glycoside/mg creatinine (95% CI: Ҁ0.0003, 0.0008 ng malvidin glycoside/mg creatinine).
The energy, nutrient, and antioxidant vitamin contents of the self-reported diets were close to that of the planned diets. No consumption of discouraged polyphenol-rich foods was reported. Nutrient intake was similar in all study phases (data not shown). Participants reported no adverse effects during the wine consumption periods. The average daily energy expended in physical activity was similar throughout the study. No weight or blood pressure changes were observed (data not shown).
Changes in lipids, homocysteine, and soluble inflammatory markers
In comparison with baseline, red wine and white wine intakes produced a significant increase in serum HDL cholesterol with a mean change of 6.7 mg/dL (95% CI: 0.5, 12.8 mg/dL) and 2.8 mg/dL (95% CI: 0.2, 5.3 mg/dL), respectively (P ҃ 0.034; both). However, no significant differences were observed between the effects of both interventions on mean serum HDL cholesterol (3.9 mg/dL; 95% CI: 2.2, 10.0 mg/dL; P ҃ 0.202). No changes were observed in other lipid values. However, homocysteine serum concentration showed an imperceptible mean increase of 0.008 mol/L (95% CI: Ҁ0.50, 0.52 mol/L; P ҃ 0.97) after the white wine intake and a not significant decrease of 0.22 mol/L (95% CI: Ҁ0.85, 0.41 mol/L; P ҃ 0.47) after the red wine period. 1 LFA-1, lymphocyte function-associated antigen 1; VLA-4, very late activation antigen 4; Mac-1, ␣M␤2; MCP-1, monocyte chemoattractant protein 1. There were no significant differences between the 2 groups before the intervention.
2 Before and after intervention. 3 Comparison between white and red wines (repeated-measures ANOVA). 4 Comparison between before and after intervention (ANOVA). 5 Comparison between measures obtained before and after intervention with white and red wines (ANOVA). 6 x Ȁ SD (all such values). 7 x; 95% CI in parentheses (all such values).
Changes in circulating concentrations of inflammatory markers are shown in Figure 1 . hsCRP, interleukin-6, ICAM-1, and CD40L decreased significantly (P 0.05) from 12% to 29% after the white wine intake, whereas hsCRP, interleukin-6, VCAM-1, ICAM-1, E-selectin, P-selectin, and CD40L were significantly (P 0.05) reduced from 17% to 39% after the red wine intake. Significant differences were observed in the effects of the 2 interventions on VCAM-1 and E-selectin, with mean changes after the red wine above those observed after the white wine of Ҁ25% (95% CI: Ҁ42%, Ҁ10%; P ҃ 0.007) and Ҁ39% (95% CI: Ҁ72%, Ҁ8%; P ҃ 0.005), respectively.
Adhesion molecule expression by PBMCs
The changes in PBMC expression of CAMs and related proteins are shown in Table 2 . After the red and white wines, the mean expression of VLA-4 and Syalil-Lewis on lymphocyte surface membranes decreased by 10% and 18% (P 0.05, both) and 5% and 6% (NS), respectively. On monocyte membranes, the mean expression of Mac-1, VLA-4, monocyte chemoattractant protein-1, and CD40 decreased between 13% and 28% after both interventions (P 0.02, all). Lymphocyte functionassociated antigen-1 and Syalil-Lewis expression, however, decreased only after the red wine intake (20% and 33%, respectively; P 0.001, both).
Monocyte adhesion to endothelial cells
As expected, after the run-in and washout periods monocyte adhesion to the TNF-␣-stimulated endothelial cells increased similarly by 46% (95% CI: 38%, 55%; P 0.001) and 48% (95% CI; 39%, 51%; P 0.001), respectively. The results were different after wine intake. Thus, with consumption of white wine, monocyte adhesion to TNF-␣-stimulated endothelial cells increased only by 24% (95% CI: 17%, 28%; P 0.001), whereas no significant changes occurred with red wine (5%; 95% CI: Ҁ4%, 13%); P ҃ 0.17) (Figure 2) . Compared with data obtained at baseline, white and red wine intakes decreased monocyte adhesion to TNF-␣-stimulated endothelial cells by 51% (95% CI: Ҁ57%, Ҁ45%; P 0.001) and 89% (95% CI: Ҁ96%, Ҁ82%; P 0.001), respectively. Regarding effects of wine intake on monocyte adhesion to stimulated endothelial cells, a significantly (P ҃ 0.010) greater decrease was observed after the red wine than after the white wine ( Table 3) .
DISCUSSION
In this clinical trial performed in 35 healthy women, consumption of 20 g alcohol/d as red wine or white wine was associated with increased HDL cholesterol and decreases in serum inflammatory biomarkers, CAM expression on monocyte surface membranes, and monocyte adhesion to endothelial cells. Red wine was usually more potent than white wine to elicit such changes.
Many epidemiologic studies have related moderate alcohol consumption to reduced rates of cardiovascular morbidity and mortality (1, 3, 5) . Part of these beneficial effects are attributed to alcohol-associated increases in both HDL cholesterol and fibrinolytic activity, as well as decreased platelet aggregation (2, 3), although other mechanisms may be involved (2) . Thus, the results of prospective studies and clinical trials show that, compared with abstainers or heavy drinkers, moderate drinkers have lower serum concentrations of inflammatory markers, such as hsCRP and interleukin-6 (7, 9, 10, 12, 21) . In small clinical trials, wine (13, 14) and beer (21) Noticeably, unlike the situation with white wine, adhesion of monocytes to stimulated endothelial cells was similar to that observed in unstimulated conditions after red wine (ie, monocytes were little activated only after red wine). Error bars are 95% CIs. *Significant differences (P 0.001) between unstimulated and TNF-␣-stimulated endothelial cells by paired Student's t test.
TABLE 3
Changes in monocyte adhesion to nonstimulated and tumor necrosis factor-␣-stimulated endothelial cells (line Ea.hy926) associated with consumption of white wine and red wine in healthy women (n ҃ 35) role in this antiinflammatory effect (22) . These beneficial effects on arterial wall inflammation-related processes add biological plausibility to the epidemiologic evidences supporting a cardioprotective effect of alcoholic beverages (23) . It is unclear, however, whether the beneficial effects of moderate alcohol consumption depend on sex, dose, or type of alcoholic beverage. Women appear to be more susceptible than men to alcoholic liver injury (24), brain disorders (25) , and cardiomyopathy (26) . Accordingly, a threshold of moderate ethanol consumption lower than that stipulated for men has been defined for women (27) . In the present study, we observed that 2 daily glasses of 100 mL wine during 4 wk reduced cellular and serum inflammatory biomarkers in women, in addition to decreasing monocyte adhesion to endothelial cells, the postulated first step in the atherosclerotic process (8) . With respect to the alcohol dose that may be safe in women, we found that the lower dose (20 g/d) taken by women was associated with beneficial effects on atherosclerotic markers similar to those observed in men consuming higher doses (30 g/d) . In fact, an updated meta-analysis of 34 prospective studies has shown that up to 2 drinks/d (20 g/d) are inversely associated with total mortality in women (28) .
Whether the beneficial effects of alcohol depend on the type of alcoholic beverage consumed has been a matter of debate. Although prospective studies found no differences among different alcoholic beverages in protection against IHD (1) or reduction in circulating inflammatory markers (7), small clinical trials showed that polyphenol-rich red wine had higher antiinflammatory effects than did gin, which is devoid of polyphenols (13, 14) . Red wine and white wine have equivalent ethanol content but dissimilar quantities of polyphenols. In our study red wine was associated with a greater reduction in inflammatory biomarkers, CAM monocyte expression, and monocyte adhesion to endothelial cells than was white wine, suggesting that the polyphenols in even small amounts of red wine are responsible in part for these beneficial effects.
However, although both wines decreased serum ICAM-1 concentrations, only red wine diminished serum concentrations of VCAM-1 and E-selectin. In fact, these adhesion molecules differ in their origin and regulation of expression. Although regulated by inflammatory cytokines, ICAM-1 is constitutively expressed by endothelial cells, whereas VCAM-1 and E-selectin are only expressed on activated endothelium. In addition, serum ICAM-1 may be synthesized by leukocytes and endothelial cells, whereas serum VCAM-1 and E-selectin are mainly synthesized by endothelium (29, 30) . These differences may explain, at least in part, why the effects of red wine were different from those of white wine on serum inflammatory biomarkers.
Limitations
One limitation is the inherent difficulty in ensuring compliance with dietary instructions, wine intake, and overall lifestyle in free-living persons. This is particularly important in a study such as ours, because diet and exercise may modify the concentrations of inflammatory markers (31, 32) . Nonetheless, adherence to the recommended diets and wine intake was good, as judged by self-reports and objective measurements, and physical activity remained constant throughout the study. However, reallife conditions may be considered a study's strength. Finally, we studied healthy women; thus, it is not possible to determine whether these salutary effects of moderate wine consumption against arterial wall inflammation are also applicable to women at high cardiovascular risk, such as those who are postmenopausal.
From our data we cannot tell which alcoholic or nonalcoholic component of wine may be responsible for the antiinflammatory effects. In this sense, previous in vitro studies have shown that different red wine polyphenols induce down-regulation of ICAM-1 and VCAM-1, reduce adhesion of U937 monocytic cells to stimulated endothelium (33) (34) (35) , prevent plateletleukocyte interactions (36, 37) , and inhibit the expression of matrix metalloproteinase-2, which is involved in atherosclerotic plaque growth and instability (38) . In recent studies comparing the effects of red wine and gin (13, 14) , we showed that both beverages (ie, ethanol itself) were associated with reduction of plasma fibrinogen, hsCRP, and interleukin-1␣, but polyphenolrich red wine had the additional effect of decreasing monocyte CAM expression. Thus, both ethanol and nonalcoholic compounds appear to contribute to the antiinflammatory effects of alcoholic beverages.
Conclusions
The mechanisms underlying the cardioprotective effect of moderate alcohol consumption are probably multifactorial (6). Our results indicate that the beneficial effects of moderate wine consumption on the vascular system may be mediated, at least in part, by a reduction in circulating inflammatory molecules, adhesion molecule expression by peripheral monocytes, and monocyte adhesion to endothelium. These salutary effects are observed in women after consumption of lower doses of alcohol as wine than those showing similar benefit in men. In probable relation with its higher polyphenol content, red wine intake is associated with superior antiinflammatory effects than is white wine in women. The results provide additional information on the beneficial role of alcoholic beverages in the prevention of low-grade inflammation and endothelial dysfunction in the arterial wall in women.
